Severe Acute Respiratory Syndrome Coronavirus-2 Pneumonia in a Newborn Treated With Remdesivir and Coronavirus Disease 2019 Convalescent Plasma
Author(s) -
Andrew J. Hopwood,
Alejandro Jordán-Villegas,
Liliana D Gutierrez,
Mallory C. Cowart,
Wilfredo Vega-Montalvo,
Wang Leung Cheung,
Michael McMahan,
Michael R. Gomez,
Federico R. Laham
Publication year - 2020
Publication title -
journal of the pediatric infectious diseases society
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.269
H-Index - 31
eISSN - 2048-7207
pISSN - 2048-7193
DOI - 10.1093/jpids/piaa165
Subject(s) - medicine , coronavirus , pneumonia , pandemic , covid-19 , convalescent plasma , respiratory system , virology , betacoronavirus , transmission (telecommunications) , disease , severe acute respiratory syndrome coronavirus , viral pneumonia , intensive care medicine , infectious disease (medical specialty) , outbreak , electrical engineering , engineering
Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is a novel pandemic virus. Mounting evidence supports the possibility of vertical transmission, which at the present time appears to be rare. We report a newborn with vertically acquired SARS-CoV-2 who developed acute respiratory failure and received remdesivir and coronavirus disease 2019 convalescent plasma.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom